Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer-Reference-Cited by-同舟云学术

Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer

Published:2015-04-12 Issue:15 Volume:6 Page:13049-13059
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chen Huiming¹²,Gao Shijuan¹,Li Jiandong¹,Liu Dong¹,Sheng Chunjie¹,Yao Chen¹²,Jiang Wei¹,Wu Jiaoxiang¹²,Chen Shuai¹³,Huang Wenlin¹³⁴

Affiliation:

1. CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China

2. School of Life Sciences, Anhui University, Hefei 230039, China

3. Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China

4. The Key Laboratory of Tumor Targeted Medicine in Guangdong Province, Guangzhou Double Bio-product Inc., Guangzhou 510663, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wedelolactone suppresses breast cancer growth and metastasis via regulating TGF-β1/Smad signaling pathway;Journal of Pharmacy and Pharmacology;2024-06-07

2. Targeting EED as a key PRC2 complex mediator toward novel epigenetic therapeutics;Drug Discovery Today;2024-06

3. Chemical inhibitors targeting histone methylation readers;Pharmacology & Therapeutics;2024-04

4. HR-MAS NMR Metabolomics Profile of Vero Cells under the Influence of Virus Infection and nsP2 Inhibitor: A Chikungunya Case Study;International Journal of Molecular Sciences;2024-01-24

5. Transcriptomic analysis of neural stem and progenitor cells in comparison with glioblastoma stem cells;Advances in Molecular Oncology;2023-12-15